Simcere Pharmaceutical Group Limited 每股年股息为 0.00,收益率为 0.00%。股息每 每年 支付,最近的除息日为 Jun 18, 2025。
股息收益率
年度股息
除息日
0.00%
$0.00
Jun 18, 2025
支付频率
派息比率
每年
0.00%
股息历史
除息日
现金金额
记录日期
付款日期
Jun 18, 2025
$0.1748
Jun 19, 2025
Jul 14, 2025
Jun 18, 2024
$0.1757
Jun 19, 2024
Jul 15, 2024
Jun 19, 2023
$0.1758
Jun 20, 2023
Jul 12, 2023
Jun 28, 2022
$0.1757
Jun 29, 2022
Jul 15, 2022
Jun 29, 2021
$0.1803
Jun 30, 2021
Jul 16, 2021
股息图表
2096.HK 股息
2096.HK 股息增长率(同比)
Follow-Up Questions
Simcere Pharmaceutical Group Limited 当前的股息支付和年度股息是多少?
Simcere Pharmaceutical Group Limited 的股息支付比率是多少?
2096.HK 的除息日是什么?
Simcere Pharmaceutical Group Limited 多久支付一次股息?
关键数据
前收盘价
$11.6
开盘价
$11.57
当日区间
$11.49 - $11.74
52周范围
$6.6 - $15.08
交易量
632.0K
平均成交量
8.5M
每股收益(TTM)
0.40
股息收益率
--
市值
$30.0B
什么是 SIMCERE PHARMA?
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.